Abstract
Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) studies were carried out for a series of thienopyrimidines, novel Histamine H1 receptor antagonists. Various models were generated. The best predictive CoMFA model gave significant correlation coefficients (cross-validated r2 (q2) = 0.514, non-cross-validated r2 = 0.925), showing the influence of steric and electrostatic fields. Likewise, the best predictive CoMSIA model gave cross-validated r2 (q2) = 0.541, non-cross-validated r2 = 0.862, eliciting the influence of steric, electrostatic, hydrophobic and hydrogen bond acceptor fields. The generated models were externally validated and well correlated with calculated (predicted) and experimental inhibitory concentration (IC50) values, using test sets. The analysis of the contour maps of both CoMFA and CoMSIA models offer important structural insight for designing novel and more active Histamine H1 receptor antagonists prior to their synthesis.
Keywords: CoMFA, CoMSIA, Thienopyrimidine derivatives, 3D QSAR, Histamine, gastric acid, rhinitis, urticaria, fever, asthma
Medicinal Chemistry
Title:CoMFA and CoMSIA 3D QSAR Models for a Series of Some Condensed Thieno[2,3-d]pyrimidin-4(3H)-ones with Antihistaminic (H1) Activity
Volume: 9 Issue: 3
Author(s): Meenakshi Singh, Sushil K. Singh, Mahesh T. Chhabria, Kamala Vasu and Dhaivat Pandya
Affiliation:
Keywords: CoMFA, CoMSIA, Thienopyrimidine derivatives, 3D QSAR, Histamine, gastric acid, rhinitis, urticaria, fever, asthma
Abstract: Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) studies were carried out for a series of thienopyrimidines, novel Histamine H1 receptor antagonists. Various models were generated. The best predictive CoMFA model gave significant correlation coefficients (cross-validated r2 (q2) = 0.514, non-cross-validated r2 = 0.925), showing the influence of steric and electrostatic fields. Likewise, the best predictive CoMSIA model gave cross-validated r2 (q2) = 0.541, non-cross-validated r2 = 0.862, eliciting the influence of steric, electrostatic, hydrophobic and hydrogen bond acceptor fields. The generated models were externally validated and well correlated with calculated (predicted) and experimental inhibitory concentration (IC50) values, using test sets. The analysis of the contour maps of both CoMFA and CoMSIA models offer important structural insight for designing novel and more active Histamine H1 receptor antagonists prior to their synthesis.
Export Options
About this article
Cite this article as:
Singh Meenakshi, K. Singh Sushil, T. Chhabria Mahesh, Vasu Kamala and Pandya Dhaivat, CoMFA and CoMSIA 3D QSAR Models for a Series of Some Condensed Thieno[2,3-d]pyrimidin-4(3H)-ones with Antihistaminic (H1) Activity, Medicinal Chemistry 2013; 9 (3) . https://dx.doi.org/10.2174/1573406411309030010
DOI https://dx.doi.org/10.2174/1573406411309030010 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Novel Benzoquinones with Anti-Inflammatory Activity
Letters in Drug Design & Discovery Apoptosis Signaling Pathways in Lung Diseases
Medicinal Chemistry Stem Cell-Based Therapies and Immunomodulatory Approaches in Newly Diagnosed Type 1 Diabetes
Current Stem Cell Research & Therapy Biochanin A Ameliorates Ovalbumin-induced Airway Inflammation through Peroxisome Proliferator-Activated Receptor-Gamma in a Mouse Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Pathophysiology of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews In-silico Inhibitory Study of cFos-cJun Complex by T-5224 Based Small Molecule Analogs
Letters in Drug Design & Discovery Quinoxalinone as a Privileged Platform in Drug Development
Mini-Reviews in Medicinal Chemistry Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews Differential Action of Phytochemicals on Platelet Apoptosis: A Biological Overview
Current Medicinal Chemistry Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
Current Medicinal Chemistry The Role of Platelets in Bone Remodeling
Inflammation & Allergy - Drug Targets (Discontinued) The Caveolin-1 Connection to Cell Death and Survival
Current Molecular Medicine Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design Long-term Exposure to Cadmium in Food and Cigarette Smoke, Liver Effects and Hepatocellular Carcinoma
Current Drug Metabolism Molecular Cloning of Blomia tropicalis Allergens - A Major Source of Dust Mite Allergens in the Tropics and Subtropics
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological and Clinical Applications of Natriuretic Peptides: Accepted Knowledges or Changing Views?
Current Pharmaceutical Analysis Therapeutic Targeting of P-Selectin in Atherosclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Internet Addiction: A Systematic Review of Epidemiological Research for the Last Decade
Current Pharmaceutical Design Domestic Arthropods and Their Allergens
Protein & Peptide Letters SAR and Molecular Modeling of N-Benzyl-N-hydroxy-3-(cyclopentyloxy)-4- methoxybenzene Carboxamide Analogues as Potent Phosphodiesterase-4 Inhibitors
Letters in Drug Design & Discovery